The Preclinical Screening Platform for Pain (PSPP) is a resource for profiling potential non-opioid pain therapeutics through in vitro screens, pharmacokinetics, assessment of side effects, and evaluation of efficacy in models of pain.

In order to validate the platform, PSPP controls, including clinically used compounds and negative controls, have been evaluated within the program. Below are links to PSPP-generated data for these control compounds.